Money Lancer
Equity: Sectoral-Pharma and Healthcare
LIC Mutual Fund
LIC Mutual Fund · Equity: Sectoral-Pharma and Healthcare

LIC MF Healthcare Fund-Regular Plan-Growth

The objective of the Scheme is to achieve long term capital appreciation by predominantly investing in equity and equity related instruments of companies engaged in Healthcare and Allied sectors. There is no assurance that the investment objective of the Scheme will be achieved.

Benchmark · BSE Healthcare TRITER · 2.44%Inception · 22-02-2019
NAV
30.96
+1.49% · as of 14-05-2026
Since inception
16.99%
CAGR
Benchmark (inception)
14.86%
CAGR
Fund size
₹1 Cr
AUM
Expense ratio
2.44%
30-04-2026
Performance

Returns vs benchmark & category

Since inception: +16.99% CAGR vs benchmark +14.86%.

Portfolio

Where the money is invested

Top holdings

SUN PHARMACEUTICAL INDUSTRIES LTD. EQ NEW F.V. RE.1/-11.77%
TORRENT PHARMACEUTICALS LIMITED EQ NEW FV RS.5/-7.08%
APOLLO HOSPITALS ENTERPRISE LIMITED EQ NEW F.V. RS.5/-6.84%
AUROBINDO PHARMA LIMITED EQ NEW F.V. RE.1/-5.21%
DIVIS LABORATORIES LIMITED EQ NEW RS. 2/-4.68%
FORTIS HEALTHCARE LIMITED. EQ4.37%
STELIS BIOPHARMA LIMITED EQ NEW FV RE.1/-4.17%
NEULAND LABORATORIES LIMITED EQ3.97%
Treps3.97%
PIRAMAL PHARMA LIMITED EQ3.94%

Sector allocation

Healthcare91.46%
Chemicals4.72%
Riskometer
LowVery High
Very High

What if you'd SIP'd here?

@ 17.0% p.a.
₹10,000
10 years
Projected value
₹31,54,364
Invested: ₹12,00,000
Gained: ₹19,54,364
Start this SIP →

Illustration based on fund's since-inception return. Past performance is not indicative of future returns.

Risk Analysis

How this fund manages risk

Fund manager
K
Karan Doshi
Manager since fund inception data not available
ISIN & identifiers
AMFI code
152025
ISIN (Growth)
INF397L01LG2
ISIN (Div Re-inv)
Status
Open Ended Schemes
Peers

Other Equity: Sectoral-Pharma and Healthcare funds

Want a personalised recommendation?

Our team will tell you whether this fund fits your goals, allocation and risk profile — and suggest peers if it doesn't.

Chat with us